Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 255-261

  Birindelli, Sarah ^a   Tragni, Gabrina ^a   Bartoli, Cesare ^a   Ranzani, Guglielmina N ^b   Rilke, Franco ^a   Pierotti, Marco A ^a   Pilotti, Silvana ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CANCER RISK; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 5Q; CHROMOSOME 9P; DNA SEQUENCE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; DNA REPAIR; DYSPLASTIC NEVUS SYNDROME; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; NEVUS, PIGMENTED; POLYMERASE CHAIN REACTION;

EID: 0034033843     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<255::AID-IJC16>3.0.CO;2-L     Document Type: Article

References (23)

1. ACKERMAN, A.B., What a naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology, 13, 241-256 (1988).
2. BONI, R., ZHUANG, Z., AKBUQUERQUE, A., VORTMEYER, A. and DURA, Y.P., Loss of heterozygosity detected on 1p and 9q in microdissected atypical nevi. Arch. Dermatol., 134, 882-883 (1998).
3. BRENTNALL, T.A., Microsatellite instability. Shifting concepts in tumorigenesis. Amer. J. Pathol., 147, 561-563 (1995).
4. BRESLOW, A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172, 902-908 (1970).
5. CANNON-ALBRIGHT, L.A. and 13 OTHERS, Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics, 23, 265-268 (1994).
6. CLARK, W.H., FROM, L., BERNARDINO, E.A. and MIHM, M.C., JR., The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Cancer Res., 29, 705-727 (1969).
7. COOK, M.G. and FALLOWFIELD, M.E., Dysplastic naevi - an alternative view. Histopathology, 16, 29-35 (1990).
8. ELDER, D.E. and MURPHY, G.F., Melanocytic tumors of the skin. Atlas of tumor pathology, Armed Forces Institute of Pathology, Washington D.C. (1990).
9. ELDER, D.E., CLARK, W.H., JR., ELENITSAS, R., GUERRY, D.P., IV and HALPERN, A.C., The early intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin. diagn. Pathol., 10, 18-35 (1993).
10. FARMER, E.R., GONIN, R. and HANNA, M.P., Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum. Pathol., 27, 528-531 (1996).
11. HEALY, E., BELGAID, C.E., TAKATA, M., VAHLQUIST, A., REHMAN, I., RIGBY, H. and REES, J.L., Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res., 56, 589-593 (1996).
12. ISSHIKI, K., SENG, B.A., ELDER, D.E., GUERRY, D.P., IV and LINNENBACH, A.J., Chromosome 9 deletion in sporadic and familial melanoma in vivo. Oncogene, 9, 1649-1653 (1994).
13. LEE, J.Y., DONG, S.M., SHIN, M.S., KIM, S.Y., LEE, S.H., KANG, S.J., LEE, J.D., KIM, C.S., KIM, S.H. and YOO, N.J., Genetic alterations of p161NK4a and p53 genes in sporadic dysplastic nevus. Biochem. biophys. Res. Comm., 237, 667-672 (1997).
14. LEVIN, D.B., WILSON, K., VALADARES DE AMORIM, G., WEBBER, J., KENNY, P. and KUSSER, W., Detection of p53 mutations in benign and dysplastic nevi. Cancer Res., 55, 4278-4282 (1995).
15. NIH CONSENSUS CONFERENCE, Diagnosis and treatment of early melanoma. J. Amer. meet. Assoc., 268, 1314-1319 (1992).
16. PARK, W.-S., VORTMEYER, A.O., PACK, S., DURAY, P.H., BONI, R., GUERAMI, A.A., EMMERT-BUCK, M.R., LIOTTA, L.A. and ZHUANG, Z., Allelic deletion at chromosome 9p21 (p16) and 17p13 (p53) in microdissected sporadic dysplastic nevus. Hum. Pathol., 29, 127-130 (1998).
17. PERIS, K., KEELER, G., CHIMENTI, S., AMANTEA, A., KERL, H. and HOFLER, H., Microsatellite instability and loss of heterozygosity in melanoma. J. invest. Dermatol., 105, 625-628 (1995).
18. QUINN, A.G., HEALY, E., REHMAN, I., SIKKINK, S. and REES, J.L., Microsatellite instability in human non-melanoma and melanoma skin cancer. J. invest. Dermatol., 104, 309-312 (1995).
19. ROBINSON, W.A., LEMON, M., ELEFANTY, A., HARRISON-SMITH, M., MARKHAM, N. and NORRIS, D., Human acquired nevi are clonal. Melanoma Res., 8, 499-503 (1998).
20. SIDRANSKY, D., Nucleic acid-based detection of cancer. Science, 270, 1054-1059 (1997).
21. SOUFIR, N., AVRIL, M.-F., CHOMRET, A., DEMENAIS, F., BOMBLED, J., SPATZ, A., STOPPA-LYONNET, D., BERNARD, J. and BRESSAC DE PAILLERETS, B., Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum. mol. Genet., 7, 209-216 (1998).
22. THIBODEAU, S.N., BREN, G.B. and SCHAID, D., Microsatellite instability in cancer of the proximal colon. Science, 260, 816-819 (1993).
23. WHITE, W.L. and HITCHOCK, M.G., Dying dogma: the pathological diagnosis of epidermotropic metastatic malignant melanoma. Semin. diagn. Pathol., 15, 176-188 (1998).